|
1
|
Begg AC, Stewart FA and Vens C: Strategies
to improve radiotherapy with targeted drugs. Nat Rev Cancer.
11:239–253. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Habibullah G, Gul R, Cassum S and Elahi R:
Experiences of the breast cancer patients undergoing radiotherapy
at a Public Hospital Peshawar Pakistan. Asia Pac J Oncol Nurs.
5:184–194. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baskar R, Dai J, Wenlong N, Yeo R and Yeoh
KW: Biological response of cancer cells to radiation treatment.
Front Mol Biosci. 1:242014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ponnusamy R, Lebedev AA, Pahlow S and
Lohkamp B: Crystal structure of human CRMP-4: Correction of
intensities for lattice-translocation disorder. Acta Crystallogr D
Biol Crystallogr. 70:1680–1694. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ponnusamy R and Lohkamp B: Insights into
the oligomerization of CRMPs: Crystal structure of human collapsin
response mediator protein 5. J Neurochem. 125:855–868. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Deo RC, Schmidt EF, Elhabazi A, Togashi H,
Burley SK and Strittmatter SM: Structural bases for CRMP function
in plexin-dependent semaphorin3A signaling. EMBO J. 23:9–22. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Minturn JE, Fryer HJ, Geschwind DH and
Hockfield S: TOAD-64, a gene expressed early in neuronal
differentiation in the rat, is related to unc-33, a C.
elegans gene involved in axon outgrowth. J Neurosci.
15:6757–6766. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nagai J, Kitamura Y, Owada K, Yamashita N,
Takei K, Goshima Y and Ohshima T: Crmp4 deletion promotes recovery
from spinal cord injury by neuroprotection and limited scar
formation. Sci Rep. 5:82692015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hiroshima Y, Nakamura F, Miyamoto H, Mori
R, Taniguchi K, Matsuyama R, Akiyama H, Tanaka K, Ichikawa Y, Kato
S, et al: Collapsin response mediator protein 4 expression is
associated with liver metastasis and poor survival in pancreatic
cancer. Ann Surg Oncol. 20 (Suppl 3):S369–S378. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tan M, Ma S, Huang Q, Hu K, Song B and Li
M: GSK-3α/β-mediated phosphorylation of CRMP-2 regulates
activity-dependent dendritic growth. J Neurochem. 125:685–697.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Matsunuma R, Chan DW, Kim BJ, Singh P, Han
A, Saltzman AB, Cheng C, Lei JT, Wang J, Roberto da Silva L, et al:
DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal
transition in claudin-low breast cancer. Proc Natl Acad Sci USA.
115:E11978–11987. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou W, Xie P, Pang M, Yang B, Fang Y, Shu
T, Liu C, Wang X, Zhang L, Li S and Rong L: Upregulation of CRMP4,
a new prostate cancer metastasis suppressor gene, inhibits tumor
growth in a nude mouse intratibial injection model. Int J Oncol.
46:290–298. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gerencser AA, Chinopoulos C, Birket MJ,
Jastroch M, Vitelli C, Nicholls DG and Brand MD: Quantitative
measurement of mitochondrial membrane potential in cultured cells:
Calcium-induced de- and hyperpolarization of neuronal mitochondria.
J Physiol. 590:2845–2871. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Molkentin JD: Calcineurin, mitochondrial
membrane potential, and cardiomyocyte apoptosis. Circ Res.
88:1220–1222. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Orrenius S, Zhivotovsky B and Nicotera P:
Regulation of cell death: The calcium-apoptosis link. Nat Rev Mol
Cell Biol. 4:552–565. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Heise N, Palme D, Misovic M, Koka S,
Rudner J, Lang F, Salih HR, Huber SM and Henke G: Non-selective
cation channel-mediated Ca2+-entry and activation of
Ca2+/calmodulin-dependent kinase II contribute to G2/M
cell cycle arrest and survival of irradiated leukemia cells. Cell
Physiol Biochem. 26:597–608. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Meyn RE, Stephens LC, Voehringer DW, Story
MD, Mirkovic N and Milas L: Biochemical modulation of
radiation-induced apoptosis in murine lymphoma cells. Radiat Res.
136:327–334. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Porporato PE, Filigheddu N, Pedro JMB,
Kroemer G and Galluzzi L: Mitochondrial metabolism and cancer. Cell
Res. 28:265–280. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Z, Majava V, Greffier A, Hayes RL,
Kursula P and Wang KK: Collapsin response mediator protein-2 is a
calmodulin-binding protein. Cell Mol Life Sci. 66:526–536. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Brittain JM, Wilson SM and Khanna
R: Emerging roles of collapsin response mediator proteins (CRMPs)
as regulators of voltage-gated calcium channels and synaptic
transmission. Commun Integr Biol. 3:172–175. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Park SY, Lee SJ, Cho HJ, Kim JT, Yoon HR,
Lee KH, Kim BY, Lee Y and Lee HG: Epsilon-globin HBE1 enhances
radiotherapy resistance by down-regulating BCL11A in colorectal
cancer cells. Cancers (Basel). 11:4982019. View Article : Google Scholar
|
|
22
|
Yokoi K, Yamashita K, Ishii S, Tanaka T,
Nishizawa N, Tsutsui A, Miura H, Katoh H, Yamanashi T, Naito M, et
al: Comprehensive molecular exploration identified promoter DNA
methylation of the CRBP1 gene as a determinant of radiation
sensitivity in rectal cancer. Br J Cancer. 116:1046–1056. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Martin M: Cutadapt removes adapter
sequences from high-throughput sequencing reads. EMBnet J.
17:10–12. 2011. View Article : Google Scholar
|
|
24
|
Dobin A, Davis CA, Schlessinger F, Drenkow
J, Zaleski C, Jha S, Batut P, Chaisson M and Gingeras TR: STAR:
Ultrafast universal RNA-seq aligner. Bioinformatics. 29:15–21.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Anders S, Pyl PT and Huber W: HTSeq-a
Python framework to work with high-throughput sequencing data.
Bioinformatics. 31:166–169. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Smaili SS, Hsu YT, Carvalho AC, Rosenstock
TR, Sharpe JC and Youle RJ: Mitochondria, calcium and pro-apoptotic
proteins as mediators in cell death signaling. Braz J Med Biol Res.
36:183–190. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Romero-Garcia S and Prado-Garcia H:
Mitochondrial calcium: Transport and modulation of cellular
processes in homeostasis and cancer (Review). Int J Oncol.
54:1155–1167. 2019.PubMed/NCBI
|
|
29
|
Schmidt EF and Strittmatter SM: The CRMP
family of proteins and their role in Sema3A signaling. Adv Exp Med
Biol. 600:1–11. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Alabed YZ, Pool M, Ong Tone S, Sutherland
C and Fournier AE: GSK3 beta regulates myelin-dependent axon
outgrowth inhibition through CRMP4. J Neurosci. 30:3635–3643. 2010.
View Article : Google Scholar
|
|
31
|
Ohtani-Kaneko R: Crmp4-KO mice as an
animal model for investigating certain phenotypes of autism
spectrum disorders. Int J Mol Sci. 20:24852019. View Article : Google Scholar
|
|
32
|
Huang QX, Xiao CT, Chen Z, Lu MH, Pang J,
Di JM, Luo ZH and Gao X: Combined analysis of CRMP4 methylation
levels and CAPRA-S score predicts metastasis and outcomes in
prostate cancer patients. Asian J Androl. 20:56–61. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo H and Xia B: Collapsin response
mediator protein 4 isoforms (CRMP4a and CRMP4b) have opposite
effects on cell proliferation, migration, and invasion in gastric
cancer. BMC Cancer. 16:5652016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sato S, Nakamura F, Hiroshima Y, Nagashima
Y, Kato I, Yamashita N, Goshima Y and Endo I: Caerulein-induced
pancreatitis augments the expression and phosphorylation of
collapsin response mediator protein 4. J Hepatobiliary Pancreat
Sci. 23:422–431. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Oya H, Kanda M, Sugimoto H, Shimizu D,
Takami H, Hibino S, Hashimoto R, Okamura Y, Yamada S, Fujii T, et
al: Dihydropyrimidinase-like 3 is a putative hepatocellular
carcinoma tumor suppressor. J Gastroenterol. 50:590–600. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Crompton M: The mitochondrial permeability
transition pore and its role in cell death. Biochem J. 341:233–249.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ravagnan L, Roumier T and Kroemer G:
Mitochondria, the killer organelles and their weapons. J Cell
Physiol. 192:131–137. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Halestrap AP, Connern CP, Griffiths EJ and
Kerr PM: Cyclosporin A binding to mitochondrial cyclophilin
inhibits the permeability transition pore and protects hearts from
ischaemia/reperfusion injury. Mol Cell Biochem. 174:167–172. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rademaker J, Schöder H, Ariaratnam NS,
Strauss HW, Yahalom J, Steingart R and Oeffinger KC: Coronary
artery disease after radiation therapy for Hodgkin's lymphoma:
Coronary CT angiography findings and calcium scores in nine
asymptomatic patients. AJR Am J Roentgenol. 191:32–37. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tagliarino C, Pink JJ, Dubyak GR, Nieminen
AL and Boothman DA: Calcium is a key signaling molecule in
beta-lapachone-mediated cell death. J Biol Chem. 276:19150–19159.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhou Y, Li R, Yu H, Wang R and Shen Z:
microRNA-130a is an oncomir suppressing the expression of CRMP4 in
gastric cancer. Onco Targets Ther. 10:3893–3905. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen S, Zhang X, Peng J, Zhai E, He Y, Wu
H, Chen C, Ma J, Wang Z and Cai S: VEGF promotes gastric cancer
development by upregulating CRMP4. Oncotarget. 7:17074–17086. 2016.
View Article : Google Scholar : PubMed/NCBI
|
